Artificial intelligence has entered reproductive medicine at nearly every stage of treatment. Here is an honest look at what it can and cannot do.
AI applications in assisted reproductive technology
The technology now supports several areas of fertility treatment:
- Treatment outcome prognosis (predicting ovarian response and IVF success)
- Optimizing hormone dosage during ovarian stimulation
- Automated ultrasound analysis for follicle counting and measurement
- Sperm selection based on morphology and motility
- Embryo quality evaluation through image analysis
- Donor-recipient compatibility optimization
AI-driven fertility prediction platforms
Multiple platforms now estimate IVF success rates. Organizations like the CDC and SART offer population-based predictions; subscription services like ExpectMore provide individualized estimates. Newer tools integrate more parameters and machine learning models.
However, interpreting these predictions requires clinical expertise. Prediction quality depends entirely on the quality and representativeness of the training data — and most clinics have different patient populations.
Time-lapse technology and AI in embryo selection
Time-lapse imaging systems like EmbryoScope use AI algorithms to assign viability scores (IdaScore, KidScore) based on embryo development patterns. These tools aim to improve embryo selection and implantation rates.
The caveat: evidence regarding their actual impact on live birth outcomes remains limited. They are promising, not proven.
Challenges and limitations
AI in fertility treatment faces several real obstacles:
- Data quality: Algorithms trained on limited or biased datasets produce inaccurate predictions.
- Reproducibility: Most tools demonstrate restricted applicability to specific clinics or populations.
- Evidence level: Most AI fertility tools present low or very low quality evidence.
- Patient confusion: Algorithmic reports can create unrealistic expectations or anxiety.
Is AI the future of reproductive medicine?
AI offers real potential across fertility treatment stages. But responsible clinical adoption requires robust scientific evidence and rigorous validation — not just technological novelty.
Our responsibility is to critically evaluate each tool, identify those with the strongest evidence, and contextualize them appropriately for each patient’s situation.
AI will remain integral to 21st-century medicine. The key is ensuring that enthusiasm for technology doesn’t outpace the evidence supporting it.
